Mazie Slater Katz & Freeman is investigating and filing claims on behalf of people nationwide who have suffered severe injuries and complications as a result of vaping, JUUL, and electronic cigarette use. Adults and teens alike, even those with no previous smoking experience, were led to believe that vaping was “much safer than cigarettes” and now find themselves addicted and suffering serious health complications. The American Journal of Physiology published a recent study concluding that chemical flavorings and additives in e-cigarettes can potentially cause more damage to the lungs than the damage caused by conventional cigarettes. If you or a loved one has died or suffered severe complications such as lung illness or brain injury as result of vaping, JUUL, or electronic cigarette use, please contact our New Jersey vaping lawyers for a free consultation.

Use of Vaping, JUUL, and E-Cigarettes may cause or increase your risk of:

Mazie Slater is a highly respected law firm located in Roseland, New Jersey. Our attorneys are currently serving as lead counsel in numerous medical device and pharmaceutical litigations.

Photo courtesy of blacknote.com and Lincoln Academy.

The risk of vaping has caused the Food and Drug Administration (“FDA”) to take historic action by sending over one thousand warning letters and administrating 131 fines to stores for the illegal sale of e-cigarettes to minors. On September 9, 2019, the FDA notified JUUL that the FDA had “determined that JUUL adulterated its products . . . by selling or distributing them as modified risk tobacco products without an FDA order in effect that permits such sale or distribution.”

Prior to sending the Warning Letter, the FDA reviewed testimony from the July 24-25, 2019 House Subcommittee hearing, documents from FDA’s inspection of JUUL’s headquarters, JUUL’s submissions to the FDA, and JUUL’s website, and found that JUUL “has engaged in labeling, advertising, and/or other activities directed to consumers, in which JUUL explicitly and/or implicitly has represented that JUUL products are free of a substance, have a reduced level of or exposure to a substance, and/or that JUUL products present a lower risk of tobacco-related disease or are less harmful than one or more other commercially marketed tobacco products.

The July 24-25, 2019 House Subcommittee hearing included the following evidence:

A JUUL representative speaking with students at his presentation stated that JUUL ‘was much safer than cigarettes’ and that ‘FDA would approve it any day.’

The JUUL representative speaking with students at his presentation called JUUL ‘totally safe.’

The JUUL representative speaking with students at his presentation stated that a student ‘…should mention JUUL to his [nicotine-addicted] friend…because that’s a safer alternative than smoking cigarettes, and it would be better for the kid to use.’

The JUUL representative speaking with students at his presentation stated, ‘FDA was about to come out and say it [JUUL] was 99% safer than cigarettes…and that…would happen very soon….’”

The FDA was particularly concerned that JUUL referred to its products as “‘99% safer’ than cigarettes, ‘much safer’ than cigarettes, ‘totally safe,’ and ‘a safer alternative than smoking cigarettes’ is particularly concerning because these statements were made directly to children in school.” The FDA’s concern is “amplified by the epidemic rate of increase in youth use of ENDS products, including JUUL’s products, and evidence that ENDS products contribute to youth use of, and addiction to, nicotine, to which youth are especially vulnerable.”

The FDA was also concerned that JUUL’s “Letter from the CEO” states: “[JUUL’s] simple and convenient system incorporates temperature regulation to heat nicotine liquid and deliver smokers the satisfaction that they want without the combustion and the harm associated with it.” On May 8, 2018, this letter appeared on JUUL’s website, which caused the FDA to use this letter as further confirmation of the evidence from the hearing testimony that JUUL has illegally marketed JUUL products as modified risk tobacco products.

Previously, in September 2018, the FDA ordered five manufacturers — Juul, British American Tobacco’s Vuse, Altria’s MarkTen, Imperial Brands’ Blu E-cigs, and Japan Tobacco’s Logic — to submit plans to address teen use of their products within 60 days.

Commissioner Gottlieb had previously released a statement stating: “E-cigs have become an almost ubiquitous — and dangerous — trend among teenagers. … The disturbing and accelerating trajectory of use we’re seeing in youth, and the resulting path to addiction, must end. The FDA cannot tolerate a whole generation of young people becoming addicted to nicotine as a tradeoff for enabling adults to access these products.”

Photo courtesy of yourvalle.net/Jacob Stanek/Independent Newsmedia.

Our law firm can help determine whether you can file a lawsuit against JUUL and potentially other companies, for selling defective E-Cigarettes and the failure to warn users about their risks.

If the vaping lawsuit is successful, you may be entitled to collect compensation for your injuries, current and future medical expenses related to the defective device, and the failure to warn of its risks, as well as for pain, suffering, disability, impairment, loss of enjoyment of life, and for lost income and wages.  If you or someone you know has a potential  Juul or vaping colaim claim, contact one of our qualified Vaping Injury Attorneys today so that we can evaluate your claim.